AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2015
Feb 3, 2015
30583_dirs_2015-02-03_06aae229-6eaa-4672-81da-80504f990a73.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2014-12-31
Reporting Person: Davis George Eric (SVP, General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-05-30 | Common Stock | G | 180 | — | Disposed | 64246 | Direct |
Footnotes
F1: Includes 10 shares acquired by the reporting person on October 31, 2014 pursuant to the issuer's Employee Stock Purchase Plan.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19